The effect of LH priming in early follicular phase on the endocrinological function of the ovary and pregnancy rate in GnRh downregulated women stimulated by exogen gonadotophins in IVF-treatment

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2005-002679-34-DK

Enrollment

150

Registered

2005-10-11

Start date

2005-11-02

Completion date

Unknown

Last updated

2017-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Interventions

Trade Name: Menopur Product Name: Menopur Product Code: menotrophin Pharmaceutical Form: Injection* INN or Proposed INN: menotrophin Current Sponsor code: 2005/135 11.aug 2005 Concentration unit: IU

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Women aged 18- 38 years in IVF-treatment Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Male infertility with low sperm count necessitating microinsemination for fertilization

Design outcomes

Primary

Measure	Time frame
Main Objective: Estimate of the effect of LH-priming in early follicular phase after 3 different stimulations regimes in IVF-treatment. ;Secondary Objective: Comparism of follicles, oocyte quality and pregnancty rate. ;Primary end point(s): Serum oestradiol on the day of hCG administration	—

Countries

Denmark

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026